Skip to content
APIScog

Roadmap

From MVP to long-term impact

APIScog is pursuing a staged route from working prototype to a validated cognitive wellbeing platform. Each stage has to earn the next: the near-term product is cognitive training, and anything clinical follows evidence rather than ambition.

The route

Five stages

  1. MVP development

    We are here

    Core environment and cognitive tasks

  2. Feasibility testing

    Usability and pilot collaborations

  3. User data and marker development

    Task performance and exploratory digital markers

  4. Validation studies

    Larger studies and evidence generation

  5. Commercial scale

    Cognitive training platform and potential diagnostic applications

Dual-path strategy

Two tracks, deliberately unequal

APIScog is initially focused on immersive VR cognitive wellbeing and cognitive training, with a near-term pathway to commercialisation. A future diagnostic model may emerge from exploratory digital markers, validation work and longitudinal research. The diagnostic pathway is investigational and not yet validated for clinical or commercial use.

  • Near termActive focus

    Training & wellbeing

    A cognitive training and wellbeing platform for a broad user base, positioned as a performance product rather than a condition-specific medical one.

  • Longer termInvestigational

    Diagnostic & clinical models

    Longitudinal data and validation studies may support development of diagnostic or monitoring models, if future evidence supports this.

Pathway to commercialisation

Where each track currently sits

MVP / Prototype

Feasibility Testing

Pilot Collaboration

Validation Studies

Regulatory Strategy

Commercial Launch

APIScog Cognitive Training

APIScog Cognitive Training: reached Feasibility Testing, stage 2 of 6.

APIScog Diagnostic Model

APIScog Diagnostic Model: reached MVP / Prototype, stage 1 of 6.

Positions mark the milestone each track has reached, not a percentage of work completed.

Why this platform

What APIScog is built to become

  • Large and growing cognitive wellbeing market

    Cognitive performance is a mainstream priority across age groups — from students and professionals to older adults seeking to maintain everyday cognition. APIScog is positioned first as a cognitive wellbeing and training platform, not a condition-specific medical product.

  • Ecologically valid VR differentiation

    Unlike abstract brain-training games, APIScog is built around life-like environments. The first MVP uses an airport-style scenario where users practise attention, working memory, processing speed, visual discrimination and response control in context.

  • Multimodal data advantage

    APIScog captures not only task performance, but also exploratory digital markers such as eye movement, head orientation and hand/controller behaviour. This creates a richer data layer around engagement, distraction, reorientation and response style.

  • Scalable platform model

    Designed as a modular platform with multiple cognitive modules, progressive difficulty levels, controlled environmental modes and future dashboard-based reporting. The architecture supports expansion across cognitive training, healthy ageing, education, occupational performance and research use cases.

Pilot partners shape the next stage

Feasibility testing and pilot collaboration are stage two, and that is where the roadmap needs people rather than plans.

APIScog is currently at MVP stage. It is not yet clinically validated and is not intended to diagnose or treat any condition. Future diagnostic or clinical applications would require appropriate validation and regulatory review.